돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 600111생성일: 2026년 10월 24일

Dimethylformamide → 3',5'-o-Bis-tert-butyldimethylsilyl-2'-deoxycytidine

https://huagongshe.com/ko/reaction/600111

반응식

참여 물질

역할이름HCID투입량
반응물DimethylformamideHCID 6228—
반응물DeoxycytidineHCID 13711—
반응물tert-Butyldimethylsilyl chlorideHCID 28928—
용매MethanolHCID 887—
생성물3',5'-o-Bis-tert-butyldimethylsilyl-2'-deoxycytidineHCID 131728726—

반응 단계

2′-deoxycytidine dC (2.85 g, 12.54 mmol), imidiazole (6.49 g, 95.31 mmol), and TBSCl (7.18 g, 47.65 mmol) were added to anhydrous DMF (27 mL) and stirred at room temperature overnight under a N2 atmosphere. Methanol (20 mL) was added, and the mixture was stirred for 30 minutes and then concentrated in vacuo. Ethyl acetate (60 mL) and water (60 mL) were then added. The organic layer was separated and washed twice with water (20 mL), and the combined aqueous layer was extracted with ethyl acetate (20 mL). The combined organic layer was dried with Na2SO4, concentrated in vacuo, and purified by silica gel chromatography to give 3′,5′-O-bis-tert-butyldimethylsilyl-2′-deoxycytidine dC.01 (4.79 g, 84%) as a white foam.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07897737B2
출처 데이터셋uspto-grants-2011_03
ORD IDord-55f76d26021948b5b4db730e8061adb4
출처 메모uspto-grants-2011_03